Summary
CVX Chart
Carvolix SA (CVX) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Carvolix SA ever had a stock split?
Carvolix SA Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | - CEO | XPAR Exchange | - ISIN |
| France Country | 76 Employees | - Last Dividend | 31 Aug 2022 Last Split | - IPO Date |
Overview
Affluent Medical SA specializes in the development of minimally invasive medical devices, focusing on the fields of urology and structural heart. Founded in 2011, the company has established its headquarters in Aix-en-Provence, France. It is dedicated to addressing some of the critical health challenges in these medical fields by leveraging innovative technologies to improve patient outcomes and quality of life. Through its commitment to innovation, Affluent Medical SA aims to become a leader in providing advanced treatments for urinary incontinence, mitral insufficiency, and abdominal aortic aneurysm.
Products and Services
Artus
An innovative, implantable electro-mechanical artificial sphincter designed by Affluent Medical SA, Artus targets moderate to severe urinary incontinence. This device represents a significant leap forward in the treatment of urinary incontinence, offering patients a more effective and minimally invasive treatment option that seeks to improve their quality of life by restoring urinary control.
Kalios
Kalios is one of Affluent Medical's groundbreaking offerings in the realm of structural heart treatments. It is an implant that is specifically designed for the treatment of mitral insufficiency, a condition where the heart's mitral valve does not close tightly, allowing blood to flow backward in the heart. Kalios aims to address this issue by providing a solution that can reduce the severity of the insufficiency and improve patient outcomes.
Epygon
Epygon is another innovative implant from Affluent Medical, created to treat mitral insufficiency. Unlike Kalios, details on how Epygon distinguishes itself in treatment approach or technology might be more specialized or cater to different patient needs or conditions within the mitral insufficiency spectrum. Regardless, it underscores Affluent Medical's commitment to offering diverse solutions tailored to patient conditions in structural heart interventions.
Kardiozis
Kardiozis represents Affluent Medical’s foray into treating abdominal aortic aneurysm with cutting-edge technology. The Kardiozis technology is designed to provide a novel treatment for abdominal aortic aneurysm, focusing on fortifying the arterial wall and preventing rupture. This approach reflects the company's expertise in creating solutions that tackle complex medical issues through minimally invasive means.
